We are monitoring the impact of COVID-19 on Therapeutic Drug Monitoring Market Get in touch with us for detailed analysis Know More
Pulished Date November, 2021
ID: 12450
Share on
Share on

Global Therapeutic Drug Monitoring Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product, Technology, Drug Class, End-User & Region (North America, Europe, Asia-Pacific, Latin America, Middle East and Africa) – Industry Forecast (2021 to 2026)

Pulished: November, 2021
ID: 12450
Pages: 190

Global Therapeutic Drug Monitoring Market Size (2021 to 2026)

The size of the global therapeutic drug monitoring market is forecasted to be growing at a CAGR of 7.33% from 2021 to 2026 and worth USD 2.48 billion by 2026 from USD 1.74 billion in 2021.

Therapeutic drug monitoring is a medical procedure for detecting the concentration of a specific drug in a patient's bloodstream at various time intervals. It's used to keep a steady volume of medication in the bloodstream without causing any side effects. Therapeutic drug monitoring is employed in just a few medications and only those with a restricted therapeutic window. It's also employed in medications that have a lot of pharmacokinetic variation. Therapeutic drug monitoring begins with the start of treatment. It includes determining a prior dosage regimen appropriate for the patient's age, BMI, weight, organ function, and other clinical factors.

Impact of COVID-19 on the global therapeutic drug monitoring market:

The demand for TDM equipment is expected to increase as a result of the COVID-19 outbreak. Researchers have been focusing on studying several potential drugs to find an appropriate treatment for COVID-19. Players in the TDM market are supplying controllers and calibrators to help laboratories meet this issue. For instance, Chromsystems delivers the 3PLUS1 calibrator with MassCheck controls, which can be used to evaluate a wide range of medicines for COVID-19 treatment. Respiratory support equipment such as an atomizer, a life-support machine, an oxygen generator, and a monitor is the most widely utilized medical devices in primary clinical care. By providing a consistent supply of personal protective equipment on the market, manufacturers of these products can profit from the rising need for medical supplies. COVID-19 is projected to have a substantial impact on the therapeutic drug monitoring market due to these factors.

MARKET DRIVERS:

The growth in the adoption and preference of personalized medicine is expected to boost the global therapeutic drug monitoring market, owing to the increased need for improved treatment outcomes with fewer adverse effects from the medication. Advanced treatment techniques such as pharmacogenomics, gene testing, and proteomics are also projected to drive market expansion. One of the primary factors fueling the growth of the global TDM market is the rise in antimicrobial resistance. The global therapeutic drug monitoring (TDM) market is also growing due to an increase in the number of people who require round-the-clock care, the number of patients admitted to healthcare institutions and a significant increase in testing volumes. One of the other key drivers for the worldwide therapeutic drug monitoring (TDM) market is the rising need for organ transplant surgeries. The importance of TDM equipment in organ transplant procedures is attributed to this trend.

TDM helps pinpoint the cause of failed therapy outcomes because it allows doctors to distinguish between the following confounding outcomes: ineffective drug treatments, patient medication non-compliance, and adverse drug reactions that may be confused with the effects of the underlying condition. The increased need to administer individualized dosage patterns is predicted to propel the TDM market forward during the forecast period.

MARKET RESTRAINTS:

Only major hospitals and reference laboratories with huge capital budgets may purchase high-volume clinical chemistry analyzers. As a result, TDM's broad use is hampered by reimbursement issues, as the costs involved with TDM are frequently substantial. In addition, poor infrastructure and skilled people are restricting market expansion in emerging economies. One of the other primary challenges in the global therapeutic drug monitoring market is the high cost of obtaining therapeutic drug monitoring treatment, which is expected to limit the market growth. Furthermore, a rigorous legal environment and a scarcity of qualified resources are significant challenges to global market expansion.

REPORT COVERAGE:

REPORT METRIC

DETAILS

Market Size Available

2020 to 2026

Base Year

2020

Forecast Period

2021 to 2026

Segments Covered

By Product, Technology, Drug Class, End-User & Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East & Africa

 

This research report on the global therapeutic drug monitoring market has been segmented and sub-segmented based on product, technology, drug class, end-user, and region.

Therapeutic Drug Monitoring Market – By Product:

  • Consumable
  • Equipment

The consumables segment held the most significant share in the global therapeutic drug monitoring market during the forecast period and is predicted to grow at a healthy CAGR. The growing need for innovative technology-based, cost-effective kits, as well as the widespread usage of these reagents in R&D, are some of the causes driving the industry's lucrative expansion.

Therapeutic Drug Monitoring Market – By Technology:

  • Fluorescence Immunoassay
  • Radioimmunoassay
  • GCMS

Due to the availability of highly specific and fluorescence immunoassays, the rising acceptance rate of new techniques, and the requirement of little training to operate the equipment, the fluorescence immunoassay segment led the market in 2020.

Therapeutic Drug Monitoring Market – By Drug class:

  • Antiepileptics
  • Antibiotics
  • Psychoactive Drugs
  • Antiarrhythmic Drugs
  • Bronchodilators
  • Immunosuppressants
  • Others

Over the forecast period, the antiepileptic medications segment is expected to lead the global therapeutic drug monitoring market during the forecast period. This dominance is due to an increase in epilepsy prevalence in recent years, which has resulted in a worldwide health burden due to the negative consequences of high blood concentrations, mandating TDM of these drugs.

Therapeutic Drug Monitoring Market – By End-User:

  • Hospitals
  • Commercial/Private Laboratories
  • Others

Due to the large number of hospitalized patients with cardiac, cancer, neurological illnesses, and HIV, hospitals cover most of the market share. Furthermore, the hospital segment is predicted to grow throughout the forecast period due to rapid growth in patient demand for hospital-attached laboratories due to increased awareness and low equipment costs.

Therapeutic Drug Monitoring Market – By Region:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • Middle East and Africa

Geographically, North America controls a significant portion of the global market and is anticipated to remain the same throughout the forecast period. The dominance is due to an increase in the worldwide prevalence of various autoimmune disorders and a sharp increase in the use of the TDM for assessing the dosage regimen in the development of treatment for various cardiac indications, as a result of the recent increase in cardiac deaths. In addition, individuals suffering from cardiovascular diseases in the United States have a higher demand for TDM, propelling the region's market.

The Asia Pacific region is expected to grow at a CAGR during the forecast period, owing to unmet needs and the government's ongoing efforts to provide low-cost services to promote individualized dosage patterns for organ transplantation cases and support personalized medicine initiatives.

KEY MARKET PARTICIPANTS:

Abbott Laboratories, Inc., Agilent Technologies, Inc., Alere, Inc., apDia Group, ARK Diagnostics, Inc., Beckman Coulter, Inc., Bio-Rad Laboratories, Inc., F. Hoffmann-La Roche AG, and Grifols, S.A. are a few of the noteworthy companies in the global therapeutic drug monitoring market profiled in this report.

RECENT HAPPENINGS IN THIS MARKET:

  • Implementing a personalized therapeutic drug monitoring (TDM) strategy at the time of infliximab beginning does not increase remission rates in patients with various inflammatory diseases, according to study data presented at the EULAR 2020 E-Congress in June 2020.
  • Hoffmann-La Roche and Blueprint Medicines collaborated in July 2020 to deliver a new treatment to people with RET-altered malignancies.
  • Abbott introduced a new test in April 2020 that can detect if you've ever had the coronavirus, and it wants to produce millions of them.
  1. Introduction                                 
    1. Market Definition                    
    2. Scope of the report                 
    3. Study Assumptions                 
    4. Base Currency, Base Year and Forecast Periods                           
  2. Research Methodology                                           
    1. Analysis Design                         
    2. Research Phases                      
      1. Secondary Research           
      2. Primary Research 
      3. Data Modelling     
      4. Expert Validation  
    3. Study Timeline                          
  3. Report Overview                                        
    1. Executive Summary                
    2. Key Inferences                       
  4. Market Dynamics                                       
    1. Impact Analysis                        
      1. Drivers      
      2. Restraints 
      3. Opportunities        
    2. Regulatory Environment                       
    3. Technology Timeline & Recent Trends                            
  5. Competitor Benchmarking Analysis                                    
    1. Key Player Benchmarking                     
      1. Market share analysis         
      2. Products/Service 
      3. Regional Presence
    2. Mergers & Acquisition Landscape                      
    3. Joint Ventures & Collaborations                        
  6. Market Segmentation                                              
    1. Global Therapeutic Drug Monitoring Market, By Product
      1. Consumable
      2. Equipment
      3. Market Size Estimations & Forecasts (2021-2026)   
      4. Y-o-Y Growth Rate Analysis              
      5. Market Attractiveness Index           
    2. Global Therapeutic Drug Monitoring Market, By Technology
      1. Fluorescence Immunoassay
      2. Radioimmunoassay
      3. GCMS
      4. Market Size Estimations & Forecasts (2021-2026)   
      5. Y-o-Y Growth Rate Analysis              
      6. Market Attractiveness Index         
    3. Global Therapeutic Drug Monitoring Market, By Drug Class        
      1. Antiepileptics
      2. Antibiotics
      3. Psychoactive Drugs
      4. Antiarrhythmic Drugs
      5. Bronchodilators
      6. Immunosuppressants
      7. Others
      8. Market Size Estimations & Forecasts (2021-2026)   
      9. Y-o-Y Growth Rate Analysis              
      10. Market Attractiveness Index         
    4. Global Therapeutic Drug Monitoring Market, By End-User          
      1. Hospitals
      2. Commercial/Private Laboratories
      3. Others
      4. Market Size Estimations & Forecasts (2021-2026)   
      5. Y-o-Y Growth Rate Analysis              
      6. Market Attractiveness Index         
  7. Geographical Landscape                                         
    1. Global Therapeutic Drug Monitoring Market, By Region                 
    2. North America - Market Analysis (2021 - 2026)                            
      1. By Country              
        1. USA
        2. Canada
    3. Europe                         
      1. By Country              
        1. UK
        2. France
        3. Germany
        4. Spain
        5. Italy
        6. Rest of Europe
    4. Asia Pacific                  
      1. By Country              
        1. China
        2. India
        3. Japan
        4. South Korea
        5. South East Asia
        6. Australia & NZ
        7. Rest of Asia-Pacific
    5. Latin America                            
      1. By Country              
        1. Brazil
        2. Argentina
        3. Mexico
        4. Rest of Latin America
    6. Middle East and Africa                           
      1. By Country              
        1. Middle East
        2. Africa
  8. Key Player Analysis                                    
    1. Abbott Laboratories, Inc.
      1. Business Description           
      2. Products/Service 
      3. Financials 
      4. SWOT Analysis      
      5. Recent Developments       
      6. Analyst Overview 
    2. Agilent Technologies, Inc.
    3. Alere, Inc.
    4. apDia Group
    5. ARK Diagnostics, Inc.
    6. Beckman Coulter, Inc.
    7. Bio-Rad Laboratories, Inc.
    8. F. Hoffmann-La Roche AG
    9. Grifols, S.A.
  9. Market Outlook & Investment Opportunities
  10. Appendix
    1. List of Tables
    2. List of Figures
  • Global, regional and country-level analysis and forecasts of the study market; providing Insights on the major countries/regions in which this industry is blooming and to also identify the regions that are still untapped.
  • Segment-level analysis in terms of product, technology, drug class and end-user along with market size forecasts and estimations to detect key areas of industry growth in detail.
  • Identification of key drivers, restraints, opportunities, and challenges (DROC) in the market and their impact on shifting market dynamics.
  • Study of the effect of exogenous and endogenous factors that affect the global market; which includes broadly demographics, economics, and political, among other macro-environmental factors presented in an extensive PESTLE Analysis.
  • Study the microenvironment factors that determine the overall profitability of an Industry, using Porter’s five forces analysis for analysing the level of competition and business strategy development.
  • A comprehensive list of key market players along with their product portfolio, current strategic interests, key financial information, legal issues, SWOT analysis and analyst overview to study and sustain the market environment.
  • Competitive landscape analysis listing out the mergers, acquisitions, collaborations in the field along with new product launches, comparative financial studies and recent developments in the market by the major companies.
  • An executive summary, abridging the entire report in such a way that decision-making personnel can rapidly become acquainted with background information, concise analysis, and main conclusions.
  • Expertly devised analyst overview along with Investment opportunities to provide both individuals and organizations a strong financial foothold in the market.
  1. Global Therapeutic Drug Monitoring Market, By Region, From 2021 to 2026 (USD Billion)
  2. Global Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  3. Global Consumable Market, By Region, From 2021 to 2026 (USD Billion)
  4. Global Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  5. Global Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  6. Global Fluorescence Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  7. Global Radioimmunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  8. Global GCMS Market, By Region, From 2021 to 2026 (USD Billion)
  9. Global Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  10. Global Antiepileptics Market, By Region, From 2021 to 2026 (USD Billion)
  11. Global Antibiotics Market, By Region, From 2021 to 2026 (USD Billion)
  12. Global Psychoactive Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  13. Global Antiarrhythmic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  14. Global Bronchodilators Market, By Region, From 2021 to 2026 (USD Billion)
  15. Global Immunosuppressants Market, By Region, From 2021 to 2026 (USD Billion)
  16. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  17. Global Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  18. Global Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  19. Global Commercial/Private Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  20. Global Others Market, By Region, From 2021 to 2026 (USD Billion)
  21. North America Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  22. North America Consumable Market, By Region, From 2021 to 2026 (USD Billion)
  23. North America Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  24. North America Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  25. North America Fluorescence Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  26. North America Radioimmunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  27. North America GCMS Market, By Region, From 2021 to 2026 (USD Billion)
  28. North America Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  29. North America Antiepileptics Market, By Region, From 2021 to 2026 (USD Billion)
  30. North America Antibiotics Market, By Region, From 2021 to 2026 (USD Billion)
  31. North America Psychoactive Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  32. North America Antiarrhythmic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  33. North America Bronchodilators Market, By Region, From 2021 to 2026 (USD Billion)
  34. North America Immunosuppressants Market, By Region, From 2021 to 2026 (USD Billion)
  35. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  36. North America Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  37. North America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  38. North America Commercial/Private Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  39. North America Others Market, By Region, From 2021 to 2026 (USD Billion)
  40. United States Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  41. United States Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  42. United States Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  43. United States Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  44. Canada Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  45. Canada Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  46. Canada Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  47. Canada Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  48. Europe Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  49. Europe Consumable Market, By Region, From 2021 to 2026 (USD Billion)
  50. Europe Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  51. Europe Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  52. Europe Fluorescence Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  53. Europe Radioimmunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  54. Europe GCMS Market, By Region, From 2021 to 2026 (USD Billion)
  55. Europe Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  56. Europe Antiepileptics Market, By Region, From 2021 to 2026 (USD Billion)
  57. Europe Antibiotics Market, By Region, From 2021 to 2026 (USD Billion)
  58. Europe Psychoactive Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  59. Europe Antiarrhythmic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  60. Europe Bronchodilators Market, By Region, From 2021 to 2026 (USD Billion)
  61. Europe Immunosuppressants Market, By Region, From 2021 to 2026 (USD Billion)
  62. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  63. Europe Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  64. Europe Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  65. Europe Commercial/Private Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  66. Europe Others Market, By Region, From 2021 to 2026 (USD Billion)
  67. U.K. Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  68. U.K. Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  69. U.K. Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  70. U.K. Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  71. Germany Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  72. Germany Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  73. Germany Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  74. Germany Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  75. France Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  76. France Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  77. France Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  78. France Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  79. Italy Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  80. Italy Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  81. Italy Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  82. Italy Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  83. Spain Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  84. Spain Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  85. Spain Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  86. Spain Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  87. Asia Pacific Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  88. Asia Pacific Consumable Market, By Region, From 2021 to 2026 (USD Billion)
  89. Asia Pacific Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  90. Asia Pacific Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  91. Asia Pacific Fluorescence Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  92. Asia Pacific Radioimmunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  93. Asia Pacific GCMS Market, By Region, From 2021 to 2026 (USD Billion)
  94. Asia Pacific Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  95. Asia Pacific Antiepileptics Market, By Region, From 2021 to 2026 (USD Billion)
  96. Asia Pacific Antibiotics Market, By Region, From 2021 to 2026 (USD Billion)
  97. Asia Pacific Psychoactive Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  98. Asia Pacific Antiarrhythmic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  99. Asia Pacific Bronchodilators Market, By Region, From 2021 to 2026 (USD Billion)
  100. Asia Pacific Immunosuppressants Market, By Region, From 2021 to 2026 (USD Billion)
  101. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  102. Asia Pacific Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  103. Asia Pacific Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  104. Asia Pacific Commercial/Private Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  105. Asia Pacific Others Market, By Region, From 2021 to 2026 (USD Billion)
  106. Japan Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  107. Japan Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  108. Japan Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  109. Japan Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  110. China Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  111. China Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  112. China Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  113. China Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  114. India Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  115. India Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  116. India Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  117. India Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  118. Australia Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  119. Australia Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  120. Australia Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  121. Australia Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  122. South Korea Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  123. South Korea Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  124. South Korea Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  125. South Korea Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  126. Latin America Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  127. Latin America Consumable Market, By Region, From 2021 to 2026 (USD Billion)
  128. Latin America Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  129. Latin America Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  130. Latin America Fluorescence Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  131. Latin America Radioimmunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  132. Latin America GCMS Market, By Region, From 2021 to 2026 (USD Billion)
  133. Latin America Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  134. Latin America Antiepileptics Market, By Region, From 2021 to 2026 (USD Billion)
  135. Latin America Antibiotics Market, By Region, From 2021 to 2026 (USD Billion)
  136. Latin America Psychoactive Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  137. Latin America Antiarrhythmic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  138. Latin America Bronchodilators Market, By Region, From 2021 to 2026 (USD Billion)
  139. Latin America Immunosuppressants Market, By Region, From 2021 to 2026 (USD Billion)
  140. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  141. Latin America Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  142. Latin America Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  143. Latin America Commercial/Private Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  144. Latin America Others Market, By Region, From 2021 to 2026 (USD Billion)
  145. Brazil Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  146. Brazil Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  147. Brazil Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  148. Brazil Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  149. Argentina Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  150. Argentina Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  151. Argentina Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  152. Argentina Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  153. Mexico Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  154. Mexico Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  155. Mexico Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  156. Mexico Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  157. Rest of Latin America Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  158. Rest of Latin America Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  159. Rest of Latin America Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  160. Rest of Latin America Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  161. Middle East and Africa Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  162. Middle East and Africa Consumable Market, By Region, From 2021 to 2026 (USD Billion)
  163. Middle East and Africa Equipment Market, By Region, From 2021 to 2026 (USD Billion)
  164. Middle East and Africa Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  165. Middle East and Africa Fluorescence Immunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  166. Middle East and Africa Radioimmunoassay Market, By Region, From 2021 to 2026 (USD Billion)
  167. Middle East and Africa GCMS Market, By Region, From 2021 to 2026 (USD Billion)
  168. Middle East and Africa Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  169. Middle East and Africa Antiepileptics Market, By Region, From 2021 to 2026 (USD Billion)
  170. Middle East and Africa Antibiotics Market, By Region, From 2021 to 2026 (USD Billion)
  171. Middle East and Africa Psychoactive Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  172. Middle East and Africa Antiarrhythmic Drugs Market, By Region, From 2021 to 2026 (USD Billion)
  173. Middle East and Africa Bronchodilators Market, By Region, From 2021 to 2026 (USD Billion)
  174. Middle East and Africa Immunosuppressants Market, By Region, From 2021 to 2026 (USD Billion)
  175. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  176. Middle East and Africa Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  177. Middle East and Africa Hospitals Market, By Region, From 2021 to 2026 (USD Billion)
  178. Middle East and Africa Commercial/Private Laboratories Market, By Region, From 2021 to 2026 (USD Billion)
  179. Middle East and Africa Others Market, By Region, From 2021 to 2026 (USD Billion)
  180. Middle East Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  181. Middle East Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  182. Middle East Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  183. Middle East Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)
  184. Africa Therapeutic Drug Monitoring Market, By Product, From 2021 to 2026 (USD Billion)
  185. Africa Therapeutic Drug Monitoring Market, By Technology, From 2021 to 2026 (USD Billion)
  186. Africa Therapeutic Drug Monitoring Market, By Drug class, From 2021 to 2026 (USD Billion)
  187. Africa Therapeutic Drug Monitoring Market, By End-User, From 2021 to 2026 (USD Billion)

Please wait. . . . Your request is being processed

Related Reports

LICENCE TYPE

$ 1234 4250

Clients
clients
clients
clients
clients
clients
clients
Click for Request Sample